BP Directors, LP
SEC CIK 1813311 · EDGAR
BoughtSold
Most active insiders at LTRN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schalop Lee Troy | Dir | $100.0K | — |
| 2 | KEYSER D JEFFREY | Dir | $100.0K | — |
BP Directors, LP made no open-market trades at LTRN in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-06-13 | 2025-06-13 | LTRN | Lantern Pharma Inc. | BP Directors, LP | 10% | S - Sale | $3.09 | -40.0K | 189.1K | -17% | -$123.6K |
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BP Directors, LP | Dir, 10% | C - Cnv Deriv | — | +9.38M | 573.4K | New | — |
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BP Directors, LP | Dir, 10% | X - OptEx | $5.27 | +38.0K | 133.6K | +40% | +$200.0K |
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BP Directors, LP | Dir, 10% | S - Sale+OE | $9.00 | -25.0K | 131.2K | -16% | -$225.0K |
| DMI | 2024-08-14 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BP Directors, LP | Dir, 10% | P - Purchase | $8.00 | +500.0K | 125.0K | New | +$4.00M |
| MI | 2024-02-29 | 2024-02-27+ | LTRN | Lantern Pharma Inc. | BP Directors, LP | 10% | S - Sale | $4.70 | -144.0K | 463.8K | -24% | -$676.3K |
| DMI | 2024-01-19 | 2024-01-17 | LTRN | Lantern Pharma Inc. | BP Directors, LP | 10% | X - OptEx | $3.13 | +79.0K | 591.0K | +15% | +$247.3K |
| DMI | 2024-01-19 | 2024-01-17 | LTRN | Lantern Pharma Inc. | BP Directors, LP | 10% | S - Sale+OE | $4.20 | -58.9K | 550.1K | -10% | -$247.3K |
| DMI | 2022-09-07 | 2022-09-02 | LTRN | Lantern Pharma Inc. | BP Directors, LP | 10% | X - OptEx | $1.03 | +32.5K | 27.3K | New | +$33.5K |
| DMI | 2022-09-07 | 2022-09-02 | LTRN | Lantern Pharma Inc. | BP Directors, LP | 10% | S - Sale+OE | $5.20 | -6,445 | 26.1K | -20% | -$33.5K |
Purchase Sale Sale after option exercise All abbreviations